Literature DB >> 629863

Antitumour responses induced by short-term pretreatment with tumour cells.

K James, R T Cullen, I Milne, M Norval.   

Abstract

The injection (s.c. or i.p.) of 10(6) live or lethally irradiated methylcholanthrene-induced fibrosarcoma cells into CBA/Ca mice one or 2 days before i.v. challenge with the same tumour inhibited the formation of artificial lung tumour metastases. In addition, it also frequently enhanced the cytostatic effect of peritoneal exudate cells on monolayers of the same tumour. The effects on lung tumour metastasis were not noted if X-irradiated tumour was injected i.v., or if s.c. administration was delayed until one day after i.v. challenge. Similar effects on tumour growth were also observed in C3Hf/Bu mice and (CBA/Ca x A/HeJ) F1 hybrids which were pretreated (s.c.) with tumour shortly before i.v. challenge with the same tumour. Further studies in CBA/Ca mice suggested that the protective effect was tumour-specific, for the growth of i.v. injected tumour was not significantly inhibited by pretreatement with a number of other MC-induced or spontaneous tumours from the same and different strains.

Entities:  

Mesh:

Year:  1978        PMID: 629863      PMCID: PMC2009583          DOI: 10.1038/bjc.1978.36

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

1.  The effects of tumour extract on macrophage proliferation in lymph-nodes.

Authors:  I Carr; P Price; S Westby
Journal:  J Pathol       Date:  1976-12       Impact factor: 7.996

2.  Inhibition of macrophage chemotaxis by neoplastic and other rapidly proliferating cells in vitro.

Authors:  S J Normann; E Sorkin
Journal:  Cancer Res       Date:  1977-03       Impact factor: 12.701

3.  An inhibitor of macrophage chemotaxis produced by neoplasms.

Authors:  R Snyderman; M C Pike
Journal:  Science       Date:  1976-04-23       Impact factor: 47.728

4.  Cytology of rheumatoid synovial cells in culture. III. Significance of isolates of epithelial cell lines.

Authors:  J M Mackay; M Norval; A Robinson; D Tait; H Hart; B P Marmion; A Muir; W A Neill
Journal:  Ann Rheum Dis       Date:  1974-09       Impact factor: 19.103

5.  The role of activated macrophages in specific and nonspecific cytostasis of tumor cells.

Authors:  J L Krahenbuhl; J S Remington
Journal:  J Immunol       Date:  1974-08       Impact factor: 5.422

6.  Activity of tumor-associated lymphoid cells at short intervals after administration of irradiated syngeneic and allogeneic tumor cells.

Authors:  B Schick; G Berke
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

7.  Depression of macrophage function by a factor produced by neoplasms: a merchanism for abrogation of immune surveillance.

Authors:  M C Pike; R Snyderman
Journal:  J Immunol       Date:  1976-10       Impact factor: 5.422

8.  Attempts to identify viruses in rheumatoid synovial cells.

Authors:  M Norval; B P Marmion
Journal:  Ann Rheum Dis       Date:  1976-04       Impact factor: 19.103

9.  Immunosuppressive activity of a subline of the mouse EL-4 lymphoma. Evidence for minute virus of mice causing the inhibition.

Authors:  G D Bonnard; E K Manders; D A Campbell; R B Herberman; M J Collins
Journal:  J Exp Med       Date:  1976-01-01       Impact factor: 14.307

10.  Biological effects of Corynebacterium parvum. 3. Amplification of resistance and impairment of active immunity to murine tumours.

Authors:  S E Smith; M T Scott
Journal:  Br J Cancer       Date:  1972-10       Impact factor: 7.640

View more
  3 in total

1.  Further studies on antitumour responses induced by short-term pretreatment with syngeneic tumour cells.

Authors:  K James; I Milne; J Merriman; W H McBride
Journal:  Br J Cancer       Date:  1979-02       Impact factor: 7.640

2.  Immunological and biochemical characteristics of acid citrate eluates from tumour cells: a major non-immunoglobulin component.

Authors:  K James; S Davis; J Merriman
Journal:  Br J Cancer       Date:  1981-03       Impact factor: 7.640

3.  Association of host immunoglobulins with solid tumours in vivo.

Authors:  K James; Y H Bessos; J Merriman
Journal:  Br J Cancer       Date:  1979-11       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.